Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth

BACKGROUND: Personalized cancer vaccines based on neoantigens have reached the clinical trial stage in melanoma. Different vaccination protocols showed efficacy in preclinical models without a clear indication of the quality and the number of neoantigens required for an effective cancer vaccine. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Aurisicchio, Luigi, Salvatori, Erika, Lione, Lucia, Bandini, Silvio, Pallocca, Matteo, Maggio, Roberta, Fanciulli, Maurizio, De Nicola, Francesca, Goeman, Frauke, Ciliberto, Gennaro, Conforti, Antonella, Luberto, Laura, Palombo, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376688/
https://www.ncbi.nlm.nih.gov/pubmed/30764846
http://dx.doi.org/10.1186/s13046-019-1084-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376688/
https://www.ncbi.nlm.nih.gov/pubmed/30764846
http://dx.doi.org/10.1186/s13046-019-1084-4

Ejemplares similares